Psoriasis: all 1,928 studies
Page 10 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)Active, not recruitingNCT06433531Phase 1
- A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisActive, not recruitingNCT06425549Phase 3
- Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis PatientsCompletedNCT06408454
- Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque PsoriasisCompletedNCT06398652Phase 3
- Biologic Therapy for Generalized Pustular PsoriasisCompletedNCT06391996
- To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal ImpairmentCompletedNCT06380153Phase 1
- Ethoximod Pharmacokinetics In Healthy SubjectsCompletedNCT06361212Phase 1
- Combination of Sotyktu and Enstilar for Plaque PsoriasisCompletedNCT06329258Phase 4
- Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesCompletedNCT06324695Not applicable
- A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCompletedNCT06323356Phase 3
- A Herbal Compound for PsoriasisActive, not recruitingNCT06301997Phase 2
- TYK2 Inhibition in Paradoxical PsoriasisTerminatedNCT06281106Phase 2/3
- An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and PsoriasisCompletedNCT06275659Not applicable
- Impact of the Mediterranean Diet on Patients with PsoriasisCompletedNCT06257641Not applicable
- Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in GreeceActive, not recruitingNCT06247319
- Role of Insulin Action in Psoriasis PathogenesisTerminatedNCT06242847
- A Clinical Trial of TQH3906 Capsules in Healthy VolunteersCompletedNCT06230588Phase 1
- Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression SymptomsCompletedNCT06216691Not applicable
- A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications DevicesCompletedNCT06182384Phase 1
- Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora CreamCompletedNCT06180473
- Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK RegistryCompletedNCT06172426
- The Effect of Ketogenic Diet Versus Mediterranean Diet in Patients With Obesity and Psoriatic ArthritisCompletedNCT06164860Not applicable
- A Clinical Study of TQH2929 in Healthy Adult SubjectsCompletedNCT06156280Phase 1
- Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With PsoriasisActive, not recruitingNCT06142357
- Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male SubjectsCompletedNCT06126718Phase 1
- Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).CompletedNCT06125808Phase 2
- Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque PsoriasisCompletedNCT06109818Phase 2
- Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee JointCompletedNCT06106230Not applicable
- Vtama in Psoriasis Patients Being Treated With Biologics.CompletedNCT06103695Phase 4
- Impact of Clinical and Psychological Factors on Treatment Satisfaction in Psoriatic Patients in Biological TherapyCompletedNCT06102356
- Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis PatientsCompletedNCT06101706Not applicable
- CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness RegistryActive, not recruitingNCT06100991
- Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human SubjectsCompletedNCT06084663Phase 3
- Hypertension, Antihypertensive Medication Use, and Risk of PsoriasisCompletedNCT06075394
- Periodontal Status in Patients With Chronic Skin DiseasesCompletedNCT06073613
- A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT06066125Phase 3
- Incretin Effect in Patients With Psoriasis and ControlsCompletedNCT06064084
- To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT06061471Phase 2
- CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical StudyCompletedNCT06050330Not applicable
- IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentCompletedNCT06049810Phase 3
- Efficacy and Safety of Infliximab Biosimilar Remsima in PsoriasisCompletedNCT06043752Phase 4
- Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in PsoriasisCompletedNCT06042647Phase 4
- A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy SubjectsCompletedNCT06033742Phase 1
- Efficacy and Safety of Apremilast in PsoriasisCompletedNCT06032858Phase 4
- Effectiveness of a Digital Health Application for PsoriasisCompletedNCT06027034Not applicable
- Koebner's Phenomenon in Psoriasis and Lichen PlanusWithdrawnNCT06021405Not applicable
- Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp PsoriasisCompletedNCT06015152Not applicable
- A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated FlaresCompletedNCT06013969Phase 4
- Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque PsoriasisCompletedNCT06011083Not applicable
- Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic DermatitisTerminatedNCT06005792Phase 1
- INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in PsoriasisCompletedNCT05971992Not applicable
- A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With BiologicsCompletedNCT05970978Phase 2
- A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.CompletedNCT05965089Phase 1
- An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)CompletedNCT05959070
- Subclinical Impairment of Cardiovascular System in Patients With PsoriasisCompletedNCT05957120
- The Disease Severity In Patients With PsoriasisCompletedNCT05943405
- Efficacy of Tildrakizumab in Difficult-to-treat Areas in PsoriasisCompletedNCT05938361
- Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic ArthritisActive, not recruitingNCT05908240Not applicable
- Online Therapist-guided Receptive Music Therapy in Adults With PsoriasisCompletedNCT05894759Not applicable
- Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.CompletedNCT05891964Phase 4
- A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp PsoriasisCompletedNCT05872256Phase 4
- A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and PsActive, not recruitingNCT05866614
- Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）CompletedNCT05863273
- The Early Detection and Progression of Subclinical Atherosclerosis in PsoriasisActive, not recruitingNCT05858099
- An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisCompletedNCT05858047Phase 2
- Study to Assess the Reliability of PASI Scoring Using Digital-Based ImagesCompletedNCT05835843
- The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis StudyCompletedNCT05820698Not applicable
- A Study of Moderate-to-severe Plaque Psoriasis Patients Response to Secukinumab Treatment in Real-world SettingCompletedNCT05787236
- The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and PsoriasisCompletedNCT05770271Not applicable
- Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy VolunteersCompletedNCT05734482Phase 1
- A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque PsoriasisCompletedNCT05728489Phase 1
- Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque PsoriasisCompletedNCT05725057Phase 1/2
- A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy VolunteersCompletedNCT05718921Phase 1
- Hormonal Associations in Male Patients With Psoriasis VulgarisStatus unknownNCT05716152
- Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque PsoriasisCompletedNCT05706870Phase 2
- Nd:YAG Laser and Radiofrequency in Treatment of Fingernail PsoriasisStatus unknownNCT05695833Not applicable
- Roflumilast Versus Methotrexate in PsoriasisCompletedNCT05684744Phase 2/3
- A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are OvertreatedCompletedNCT05683054Phase 4
- PMS of Spesolimab I.V. in GPP Patients With Acute SymptomsCompletedNCT05670821
- VTX958 Versus Placebo for the Treatment of Moderate to Severe PsoriasisTerminatedNCT05655299Phase 2
- Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque PsoriasisCompletedNCT05650060
- Effect Narrow-Band UVB RadiationsCompletedNCT05647187Not applicable
- A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque PsoriasisCompletedNCT05645627Phase 3
- A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in JapanCompletedNCT05633264
- Response of Metabolic Syndrome and Sexual Dysfunction to Lifestyle Changes in Men With PsoriasisStatus unknownNCT05632042Not applicable
- Psorcast Mobile StudyActive, not recruitingNCT05621369
- A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisStatus unknownNCT05604898Phase 2
- Adherence to OtezlaWithdrawnNCT05601492Early Phase 1
- Role of Intermittent Fasting in Psoriasis and Psoriatic ArthritisCompletedNCT05590247Not applicable
- The Study of Koebner in Patients With Psoriasis and Psoriatic ArthritisCompletedNCT05589298
- Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic DiseasesCompletedNCT05571696Not applicable
- Deucravacitinib Adherence StudyActive, not recruitingNCT05570955Not applicable
- Effect of Long-term Psoriasis on Patients' Life - CORONATECompletedNCT05555953
- Excimer Laser With Topical Agents in Psoriasis VulgarisStatus unknownNCT05555797Phase 4
- A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque PsoriasisCompletedNCT05547490
- A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT05536726Phase 3
- A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT05531682Phase 2
- KX01 Ointment Phase 1 Study in Patients With Plaque Type PsoriasisCompletedNCT05522816Phase 1
- A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical CreamCompletedNCT05514353Phase 1
- Impact of Secukinumab on Clinical and Patient Reported Outcomes in Patients With PsoriasisCompletedNCT05513014